Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is S&W Seed Company (SANW) Going to Burn These Hedge Funds?

Page 1 of 2

Is S&W Seed Company (NASDAQ:SANW) a good stock to buy right now? We at Insider Monkey like to examine what billionaires and hedge funds think of a company before doing days of research on it. Given their 2 and 20 payment structure, hedge funds have more resources than the average investor. The funds have access to expert networks and get tips from industry insiders. They also have numerous Ivy League graduates and MBAs. Like everyone else, hedge funds perform miserably at times, but their consensus picks have historically outperformed the market after risk adjustments.

Is S&W Seed Company (NASDAQ:SANW) a sound investment today? Money managers are getting less bullish. The number of long hedge fund bets dropped by 1 in recent months. S&W Seed Company (NASDAQ:SANW) was in 5 hedge funds’ portfolios at the end of September. There were 6 hedge funds in our database with S&W Seed Company (NASDAQ:SANW) positions at the end of the previous quarter. The stock trading sentiment was quite similar to the hedge fund sentiment, as the shares of S&W Seed Company (NASDAQ:SANW) were down 5.74% during the quarter. We will find out more about the hedge funds that held positions in the company, at the end of September.

For an in-depth understanding of the hedge fund sentiment surrounding stocks with similar market caps, we will also compare S&W Seed Company (NASDAQ:SANW) to other stocks, including Ocera Therapeutics Inc (NASDAQ:OCRX), AXT Inc (NASDAQ:AXTI), and BlueLinx Holdings Inc. (NYSE:BXC) to get a better sense of its popularity.

Follow S&w Seed Co (NASDAQ:SANW)
Trade (NASDAQ:SANW) Now!

In the eyes of most stock holders, hedge funds are assumed to be underperforming, old financial vehicles of yesteryear. While there are greater than 8000 funds in operation at present, our experts look at the crème de la crème of this club, around 700 funds. These hedge fund managers direct the lion’s share of the hedge fund industry’s total asset base, and by keeping track of their finest investments, Insider Monkey has unsheathed several investment strategies that have historically beaten the market. Insider Monkey’s small-cap hedge fund strategy defeated the S&P 500 index by 12 percentage points per year for a decade in their back tests.

Keeping this in mind, we’re going to take a look at the key action encompassing S&W Seed Company (NASDAQ:SANW).

What have hedge funds been doing with S&W Seed Company (NASDAQ:SANW)?

At the end of the third quarter, a total of 5 of the hedge funds tracked by Insider Monkey were long this stock, a decline of 17% from the second quarter. With hedge funds’ positions undergoing their usual ebb and flow, there exists a few key hedge fund managers who were upping their stakes meaningfully (or already accumulated large positions).

According to Insider Monkey’s hedge fund database, MFP Investors, managed by Michael Price, holds the most valuable position in S&W Seed Company (NASDAQ:SANW). MFP Investors has a $6 million position in the stock, comprising 0.9% of its 13F portfolio. Sitting at the No. 2 spot is Coe Capital Management, managed by Mark Coe, which holds a $0.8 million position; the fund has 0.3% of its 13F portfolio invested in the stock. Other peers with similar optimism encompass Ken Grossman and Glen Schneider’s SG Capital Management, and Renaissance Technologies.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!